Adam Bress

@adambress

Dad | Husband | Brother | Friend | Univ of Utah Researcher | Hypertension Symposium Director: | CVD Clinical Pharmacist | Runner

Salt Lake City, UT
Vrijeme pridruživanja: lipanj 2009.

Tweetovi

Blokirali ste korisnika/cu @adambress

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @adambress

  1. Prikvačeni tweet
    12. lis 2019.

    Huge thanks to , , Dr. Miner, and for kicking off the Third Annual University of Utah Translational Hypertension and Early-Stage Investigator Workshop

    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet

    A new study warns of the role certain kinds of may play in increasing risk and premature death. Hear more from senior author Norrina Allen, PhD:

    Prikaži ovu nit
    Poništi
  3. proslijedio/la je Tweet
    2. velj

    Anthony Schaeffer has been awarded a NIH-K08 award to study infants with hydronephrosis detected in utero. Huge congrats!! ⁩ ⁦

    Poništi
  4. 3. velj

    We cannot wait to host and learn causal inference again from at May 13th and 14th, 2020! Registration link below

    Poništi
  5. proslijedio/la je Tweet
    31. sij

    👁 opening read in ⁦⁩ this morning “A majority of state boards do not require pharmacies to report errors, let alone conduct thorough investigations when they occur.” ⁦⁩ ⁦ via

    Poništi
  6. proslijedio/la je Tweet
    31. sij

    😞Big story this morning on pharmacist work conditions in chain pharmacies. I’m not surprised but still disapointing — via

    Poništi
  7. proslijedio/la je Tweet
    31. sij

    This is not a good look for an industry that aims to expand into other areas of healthcare.

    Poništi
  8. proslijedio/la je Tweet
    30. sij
    Odgovor korisnicima i sljedećem broju korisnika:

    It was retracted the same day that the AHA statistical update 2020 came out. Unfortunately, it made it into this very influential document on pg. e123

    Poništi
  9. proslijedio/la je Tweet
    30. sij

    Similar RR reduction (~20% per 1 mmol/lL) with lipid-lowering therapy (statins, ezetimibe, PCSK9 inhibitors) regardless of baseline LDL-C (even 2.60 mmol/L or lower)

    Poništi
  10. proslijedio/la je Tweet
    29. sij

    The submission deadline for has been EXTENDED! Submit by Monday, February 3rd at 9:00 AM CT here - . Please RT!

    Poništi
  11. proslijedio/la je Tweet

    Thank you for this preview of my upcoming book "Together: The Healing Power of Human Connection in a Sometimes Lonely World.” Looking forward to sharing all the stories and lessons I was blessed to encounter over these last few years.

    Poništi
  12. proslijedio/la je Tweet
    27. sij

    Competing events are responsible for much confusion in studies. What to do when some individuals die before developing the event of interest? If you were taught that censoring individuals who die is mandatory or that using hazards helps, please read our paper 👇

    Poništi
  13. proslijedio/la je Tweet
    24. sij

    Routine PRO collection requires concerted effort, and support from HF providers, the hospital, and...patients.

    Poništi
  14. proslijedio/la je Tweet
    27. sij

    Our paper on orthostatic hypotension in is out! Big thanks to all the co-authors who made this possible. Orthostatic Hypotension, Cardiovascular Outcomes, and Adverse Events | Hypertension

    Poništi
  15. proslijedio/la je Tweet
    27. sij

    Post-hoc of SPRINT showing no need to down titrate therapy in patients with asymptomatic orthostatic hypotension - not a surprise really but reassuring

    Poništi
  16. proslijedio/la je Tweet

    SCOOP: Bolton book draft, circulated to associates and sent to WH for review process, describes a convo w POTUS where he says he doesn't want to release withheld aid till Ukraine turned over material related to investigations and me

    Poništi
  17. proslijedio/la je Tweet
    24. sij
    Poništi
  18. proslijedio/la je Tweet
    23. sij

    . has a medical director of antibiotic stewardship who: • Tracks metrics on antibiotic use • Analyzes resistance patterns • Reviews latest medical literature

    Poništi
  19. proslijedio/la je Tweet
    23. sij

    Interesting paper from and others. First study comparing a wearable watch-type monitor with a conventional ambulatory monitor.

    Poništi
  20. proslijedio/la je Tweet
    22. sij

    Check out this work by past chair Shannon Finks & colleagues in !!! “Treating Hypertension in Chronic Obstructive Pulmonary Disease” | NEJM

    Poništi
  21. proslijedio/la je Tweet
    17. sij

    2 pubs & a travel award in 1 week! 2020! -- Reviewer #2 on my lead author piece: "The work is impactful & offers critical insight into rural-urban difference on survival."

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·